Bone marrow transplantation for therapy in autoimmune disease

Stem Cells

Volumn 15, Issue SUPPL. 1, 1997, Pages 171-176

  Exner, Beate G ^a   Groninger, James H ^a   Ildstad, Suzanne T ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Bone marrow transplantation; Chimerism; Conditioning; Diabetes; Facilitating cell; NOD

Indexed keywords

AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CHIMERA; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; IMMUNOCOMPETENCE; MORBIDITY; MORTALITY;

ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; HUMANS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 0030664607     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150822     Document Type: Article

References (39)

1. Hochberg MC. Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. Epidemiol Rev 1981;3:27-44.
2. Lloyd CE, Becker D, Ellis D et al. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis. Am J Epidemiol 1996;143:431-441.
3. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug induced aplastic anaemia. Bone Marrow Transplant 1986;1:237-239.
4. Lowenthal RM, Cohen ML, Atkinson K et al. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993;20:137-140.
5. Liu Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992;9:31-33.
6. Eedy DJ, Burrows D, Bridges JM et al. Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J 1990;300:908-909.
7. Vialettes B, Maraninchi D, San Marco MP et al. Autoimmune polyendocrine failure - Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism - after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia. Diabetologia 1993;36:541-546.
8. Lampeter EF, Homberg M, Quabeck K et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993;341:1243-1244; Comment: Vialettes B, Maraninchi D. Lancet 1993;342:174.
9. Bernard CCA, Mandel TE, Mackay IR. Experimental models of human autoimmune disease: overview and prototypes. In: Mackay IR, Rose N, eds. The Autoimmune Diseases II. San Diego-Toronto: Academic Press 1992:47-106.
10. Ikehara S, Ohtsuki H, Good RA et al. Prevention of Type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82:7743-7747.
11. LaFace DM, Peck AB. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 1989;38:894-901.
12. Serreze DV, Leiter EH, Worthen SM et al. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD X NON) F1 mice. Diabetes 1988;37:252-255.
13. Morton JL, Siegel BV. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-II histocompatible recipients of bone marrow from New Zealand black mice. Proc Natl Acad Sci USA 1974;71:2162-2165.
14. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:8341-8344.
15. Zinkernagel RM, Althage A, Callahan G et al. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol 1980;124:2356-2365.
16. Singer A, Hathcock KS, Hodes RJ. Self-recognition in allogeneic radiation bone marrow chimeras: a radiation-resistant host element dictates the self-specificity and immune response gene phenotype of T-helper cells. J Exp Med 1981;153:1286-1301.
17. Touraine JL, Roncarolo MG, Plotnicky H et al. T lymphocytes from human chimeras do recognize antigen in the context of allogeneic determinants of the major histocompatibility complex. Immunol Lett 1994;39:9-12.
18. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307:168-169.
19. Ruedi E, Sykes M, Ildstad ST et al. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 → P1) irradiation chimeras. Cell Immunol 1989;121:185-195.
20. Ildstad ST, Wren SM, Bluestone JA et al. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985;162:231-244.
21. Mathieu C, Vandeputte M, Bouillon R et al. Protection against autoimmune diabetes by induction of mixed bone marrow chimerism. Transplant Proc 1993;25:1266-1267.
22. Kaufman CL, Li H, Ildstad ST. Patterns of hematopoietic reconstitution in NOD mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. J Immunol 1997;158:2435-2442.
23. Wood M, Monoco A. Models of specific unresponsiveness to tissue allografts in anti-lymphocyte serum (ALS) treated mice. Transplant Proc 1978;10:379-380.
24. Cobbold SP, Martin G, Qin S et al. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986;323:164-166.
25. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493-502.
26. Colson YL, Wren SM, Schuchert MJ et al. A non-lethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor and hematopoietic histocompatibility barriers. J Immunol 1995;155:4179-4188.
27. Colson YL, Li H, Boggs Sallie S et al. Durable mixed allogeneic chimerism and tolerance by a non-lethal radiation-based cytoreductive approach. J Immunol 1996;157:2820-2829.
28. Li H, Kaufman CL, Boggs SS et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulinitis in nonobese diabetic (NOD) mice. J Immunol 1996;156:380-388.
29. Lepault F, Gagnerault MC, Dardenne M et al. Hematopoietic stem cells and myeloid precursor cells in nonobese diabetic (NOD) mice. Int J Cell Cloning 1992;10:173-181.
30. Langmuir PB, Bridgett MM, Bothwell AL et al. Bone marrow abnormalities in the non-obese diabetic mouse. Int Immunol 1993;5:169-177.
31. Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 1993;90:9625-9629.
32. Leijon K, Hammarströem B, Holmberg D. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 1993;6:339-345.
33. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/lt mice. J Immunol 1993;150:2534-2543.
34. Serreze DV. Autoimmune diabetes results from genetic defects manifested by antigen presenting cells. FASEB J 1993;7:1092-1096.
35. Sobel CS, Kakkanaiah VN, Cohen PL et al. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int Immunol 1993;5:1275-1278.
36. Li H, Colson Y, Ildstad ST. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation 1995;60:523-529.
37. Li H, Kaufmann CL, Ildstad ST. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 1995;8:192-198.
38. Kawai T, Cosimi B, Colvin RB et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995;59:256-262.
39. Kaufmann CL, Colson YL, Wren SM et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994;84:2436-2446.